Loading clinical trials...
Loading clinical trials...
Almost 50 % of papillary thyroid cancer (PTC) patients have central lymph node metastases (CLNM), which are associated with a high risk of persistent or recurrent disease. However, the practice of per...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Medical Center Groningen
Collaborators
NCT06316895 · Papillary Thyroid Cancer
NCT07140757 · Low Risk, Papillary Thyroid Cancer, and more
NCT05024929 · Papillary Thyroid Cancer, Pediatric Cancer, and more
NCT05000827 · Prostate Cancer Metastatic, Prostate Cancer, and more
NCT04744506 · Breast Cancer, Surgery, and more
University Medical Center Groningen
Groningen
Erasmus Medical Center
Rotterdam
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions